Immediate Impact

1 by Nobel laureates 20 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Long COVID science, research and policy
2024 Standout
1 intermediate paper

Works of Esther Melamed being referenced

Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of neurologic sequelae in patients with post‐acute sequelae of SARS‐CoV‐2 infection (PASC)
2023
Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
2020

Author Peers

Author Last Decade Papers Cites
Esther Melamed 166 157 245 404 34 929
B Noël 19 48 316 438 62 939
Linda Hasadsri 88 25 361 303 37 859
Jörg Schmidtke 22 39 328 221 55 1.1k
Akira Kuwano 149 33 640 512 28 1.2k
Jürgen Herrmann 25 40 412 406 30 958
Emmelien Aten 16 97 568 329 16 984
Santasree Banerjee 49 60 380 233 37 794
Cornelia Epplen 12 86 327 169 26 844
John Melnyk 22 30 352 371 28 833
Ernesto Lowy 11 23 401 319 23 967

All Works

Loading papers...

Rankless by CCL
2026